Streetbeat News

Partnerships

AVAX-USD

Avalanche (CRYPTO: AVAX) has seen a significant increase in value, rising over 6% in the past 24 hours and 76% over the past week, outperforming the top 20 cryptocurrencies. Coinshares reported $2 million in inflows into Avalanche, and analyst Jacob Canfield expressed a bullish outlook on AVAX. Large transactions have been frequent, and JPMorgan and Apollo's interest in using Avalanche for asset tokenization may be supporting its price. Coincheck recently listed AVAX, and over $275 million in AVAX has been allocated to reward validators, emphasizing the community's commitment to a robust network.

Portfolio Pulse from Khyathi Dalal

December 11, 2023 | 10:25 pm

MSFT

Microsoft Corp (NASDAQ:MSFT) has included 77 temporary game testers from ZeniMax Studios into a quality assurance union, with 23 testers becoming full-time employees and all testers receiving raises. The unionization has also provided testers with paid holidays, sick time, and complimentary copies of Starfield. This move by Microsoft, following its acquisition of ZeniMax's parent Bethesda for $8.1 billion in 2020, sets a new standard in the gaming industry's labor practices and contrasts with allegations against Sega of America for threatening unionized staff.

Portfolio Pulse from Franca Quarneti

December 11, 2023 | 10:06 pm

SNY

Maze Therapeutics is reviewing the FTC's action to block their collaboration and license agreement with Sanofi concerning MZE001. The company is considering its legal and business options in response to the FTC's move.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:57 pm

CMG

DPZ

SBUX

UBER

Benchmark analyst Todd Brooks upgraded Domino's Pizza Inc (NYSE:DPZ) from Hold to Buy with a price target of $455, citing potential growth from a revamped loyalty program and a nationwide launch on Uber Eats. Brooks compared Domino's technology platform favorably with industry leaders like Starbucks and Chipotle. He expects Domino's to achieve over 3% same store sales growth in the U.S. and highlighted management's forecasts for global retail sales and operating income growth. Domino's stock closed up 0.65% at $397.48 on Monday.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 9:50 pm

MGRX

Mangoceuticals has entered into a marketing agreement with Marius Pharmaceuticals, according to a Dec. 10 SEC 8K filing. The agreement grants Mangoceuticals the rights to use the trademark 'Kyzatrex' for oral testosterone undecanoate softgel capsules and allows them to sell Kyzatrex on their website.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:30 pm

AMRC

Ameresco, Inc. has been awarded contracts to develop two clean energy facilities by Hawaiian Electric Company. This move aligns with the increasing demand for renewable energy solutions and may positively impact Ameresco's revenue and growth prospects in the renewable energy sector.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:23 pm

SAIC

SAIC has announced a realignment of its organization aimed at reducing hierarchy, fostering innovation, expanding business development, and enhancing customer intimacy. This strategic move is designed to streamline operations and improve the company's competitive edge in the market.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:23 pm

BMY

SystImmune and Bristol Myers Squibb (BMY) have entered into an exclusive agreement for the development and commercialization of BL-B01D1. BMY will make an $800 million upfront payment to SystImmune, with the potential for up to $500 million in near-term payments. Additionally, SystImmune could receive up to $7.1 billion in milestone payments.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:19 pm

SNY

Sanofi expressed disagreement with the FTC's decision to seek a preliminary injunction against its proposed licensing agreement with Maze Therapeutics for MZE001, a potential treatment for Pompe Disease. The FTC's action delays the development of the drug, which has completed Phase 1 trials. Sanofi has decided to terminate the agreement with Maze to avoid a protracted legal battle, despite the potential benefits for patients with Pompe Disease.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:15 pm

AMD

AMZN

GOOG

INTC

MSFT

NVDA

AMD and Amazon are challenging Nvidia and Microsoft in the AI chip market. AMD unveiled new AI chips and raised its market value forecast for AI chips to $400 billion by 2027. Amazon announced new AWS-designed AI chips, aiming to compete with Microsoft's early AI advantage and deepened its partnership with Nvidia by offering access to next-generation H200 Tensor Core GPUs. Both AMD and Amazon are positioning themselves as strong competitors in the AI and cloud computing sectors.

Portfolio Pulse from Upwallstreet

December 11, 2023 | 7:23 pm